文献速递口腔颌面外科口腔修复与种植

三维打印聚乳酸-羟基乙酸共聚物/磷酸三钙支架用于骨重建的生物学评价

[Biological evaluation of three-dimensional printed co-poly lactic acid/glycolic acid/tri-calcium phosphate scaffold for bone reconstruction].
PubMed 文献 · Zhonghua Kou Qiang Yi Xue Za Zhi · 2016-01-01

本研究通过低温快速成型技术制备三维打印PLGA/TCP支架,表征其形貌并评估MC3T3-E1细胞相容性,同时将负载不同剂量rhBMP-2的支架植入大鼠背阔肌异位成骨。结果显示支架孔隙率(73±3)%、细胞相容性良好,低剂量组异位成骨形态类似预植支架,高剂量组成骨过多形态多样,作者认为需进一步研究验证其修复口腔颌面部骨缺损的效果。

要点

  • 三维打印PLGA/TCP支架孔隙率(73±3)%,具有规则多孔立体结构。
  • 浸提液组第1、2天吸光度显著高于空白对照组(P<0.05),第3天无显著差异(P>0.05)。
  • 负载rhBMP-2的支架在大鼠背阔肌内形成明显异位新骨,低剂量组形态类似预植支架,高剂量组成骨过多形态多样。

核心结论

  • 三维打印技术可制备个性化PLGA/TCP支架,该支架具有优异的生物相容性,负载rhBMP-2后具有异位成骨能力,但需进一步研究验证其修复口腔颌面部骨缺损的效果。

研究设计与样本

  • 采用低温快速成型技术制备PLGA/TCP支架,用微型CT和扫描电镜表征表面形貌。
  • 将MC3T3-E1细胞接种于支架,经罗丹明鬼笔环肽和钙黄绿素乙酰甲氧基染色后用共聚焦激光扫描显微镜观察细胞特征与活性。
  • 将细胞分别与PLGA/TCP浸提液和完全培养基共培养,用CCK-8法在第1、2、3天评估细胞增殖能力。
  • 将负载0、30、60 μg rhBMP-2的PLGA/TCP支架(即空白对照组、低剂量组和高剂量组)植入大鼠背阔肌,6周后取材评估新骨体积与形态。

主要发现

  • 三维打印PLGA/TCP支架具有规则、界限清晰的多孔立体结构,孔隙率为(73±3)%。
  • 微型CT和扫描电镜显示孔径分别为(379±32)和(453±29)μm,层间距分别为(452±24)和(415±25)μm,圆柱直径分别为(342±24)和(350±28)μm。
  • 罗丹明鬼笔环肽和钙黄绿素乙酰甲氧基染色显示支架外表面和内表面均具有优异的细胞黏附和生长能力。
  • CCK-8检测显示浸提液组第1天吸光度(0.51±0.08)和第2天(0.63±0.09)显著高于空白对照组(0.39±0.05和0.53±0.05)(P<0.05),第3天浸提液组(0.67±0.06)与空白对照组(0.68±0.04)无显著差异(P>0.05)。
  • 体内实验中,负载rhBMP-2的PLGA/TCP支架可见明显异位新骨形成,经组织学检查和微型CT证实;低剂量组成骨形态与预植三维打印支架相似,高剂量组因成骨过度而形态多样,经大体观察、组织学和微型CT验证。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 作者指出需进一步研究验证该支架修复口腔颌面部骨缺损的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To biologically evaluate the three-dimensional(3D) printed co-poly lactic acid/glycolic acid/tri-calcium phosphate(PLGA/TCP) scaffold which could be used for repairing oral and maxillofacial bone defects, and to provide experimental evidence for its further research and clinical application. Methods: PLGA/TCP scaffolds were fabricated using low temperature rapid prototyping technique. Micro-CT and scanning electron microscope(SEM) were used to characterize the surface morphology. MC3T3-E1 cells were seeded onto the scaffold and stained with the rhodamine phalloidin and calcein acetomethoxy. After that, confocal laser scanning microscope was exploited to observe the features and viability of the cells. Moreover, the cells were co-cultured with the extract of PLGA/TCP and complete medium, respectively. The proliferation capability of the cells was assessed by the cell counting kit-8 (CCK-8) on the 1st, 2nd, and 3rd day. The PLGA/TCP scaffolds incorporated with recombinant human bone morphogenetic protein-2(rhBMP-2) of 0, 30, 60 μg(i.e. blank control group, low-dose group and high-dose group) were implanted into the latissimus dorsi muscle of the rats, and 6 weeks later, the samples were harvested to estimate the volume and pattern of new bone. Results: The 3D printed PLGA/TCP scaffold possessed a regular and well-defined porous stereo-structure with porosity of (73±3)%. Micro-CT and SEM showed that pore size were (379±32) and (453±29) μm respectively, and distance between layers were (452± 24) and (415±25) μm, and cylinder diameter were (342±24) and (350±28) μm. It also exhibited excellent cell adhesion and growth ability on the exterior and inner surface through rhodamine phalloidin and calcein acetomethoxy staining. The CCK-8 test demonstrated that the absorbance value of extract group on the 1st and 2nd day(0.51±0.08 and 0.63±0.09) were significantly higher than those in the blank control group(0.39± 0.05 and 0.53±0.05)(P<0.05), while there was no significant difference between the extract group(0.67±0.06) and the blank control group(0.68±0.04)(P>0.05) on the 3rd day. For in vivo test, there was obvious ectopic new bone formation on the PLGA/TCP scaffold incorporated with rhBMP-2, and this was demonstrated using the histological examination and micro-CT. The bone formation in the low-dose group was similar to the shape of the pre-implanted 3D printed scaffold, while much diversity was revealed in the high-dose group duo to over osteogenesis which was validated by the examinations of gross observation, histology and micro-CT. Conclusions: Customized PLGA/TCP scaffolds can be manufactured by 3D printing technique. The scaffold showed an excellent biocompatibility and ectopic osteogenesis when incorporated with rhBMP-2. However, further research is needed to validate it's effect on repairment of the oral and maxillofacial bone defects.

来源:Zhonghua Kou Qiang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li SY, Zhou M, Lai YX, et al. [Biological evaluation of three-dimensional printed co-poly lactic acid/glycolic acid/tri-calcium phosphate scaffold for bone reconstruction]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2016. PMID: 27806758. doi:10.3760/cma.j.issn.1002-0098.2016.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。